Skip to main content

Velan Capital Investment Management LP

13F filer · CIK 0001848809
Reported Aug 14, 2026
Net seller this quarter
13F portfolio value$164MU.S. long equity reported on 13F
Positions506 new · 5 closed
Net flow last quarter-$6MBuys minus sells
Top 10 positions weight74.8%Concentration

Holdings

13F · last 4 quarters free
Scroll for earlier quarters
CompanyValue% of portfolio% of companyPOSITION CHANGE qoq %First reported
Q2 2026Reported Aug 14, 202650 positions
PRAXPraxis Precision Medicines, Inc.$29.7M18.10%0.32%-11.9%Q1 2023
MPLTMapLight Therapeutics, Inc.$17.7M10.76%1.08%Not reportedQ4 2025
STROSutro Biopharma, Inc.$17M10.36%3.09%Not reportedQ4 2024
IMMXImmix Biopharma, Inc.$11.2M6.81%1.52%+46.6%Q2 2025
TARAProtara Therapeutics, Inc.$10.9M6.62%4.81%+0.4%Q2 2024
ABVXAbivax S.A.$8.75M5.33%0.08%-14.8%Q3 2025
TENXTenax Therapeutics, Inc.$8M4.87%1.72%-5.7%Q3 2024
AVRAnteris Technologies Global Corp.$6.9M4.20%0.72%Not reportedQ1 2026
EDSAEdesa Biotech, Inc.$6.73M4.10%8.59%Not reportedQ4 2022
EVMNEvommune, Inc.$6M3.65%1.24%+1.1%Q4 2025
AVTXAvalo Therapeutics, Inc.$6M3.65%0.61%+75.3%Q4 2024
XNCRXencor Inc$4.11M2.50%0.34%+2.0%Q1 2026
RZLTRezolute, Inc.$3.9M2.38%0.78%Not reportedQ4 2021
HRTXHeron Therapeutics, Inc.$3.74M2.28%4.62%Not reportedQ4 2022
VRCAVerrica Pharmaceuticals Inc.$2.89M1.76%2.75%Not reportedQ4 2025
CCCCC4 Therapeutics, Inc.$2.66M1.62%0.46%NewQ2 2026
EPRXEupraxia Pharmaceuticals Inc.$2.33M1.42%0.68%Not reportedQ3 2025
ADMAAdma Biologics, Inc.$2.09M1.27%0.11%Not reportedQ4 2021
RNTXRein Therapeutics, Inc.$1.77M1.08%1.98%NewQ2 2026
LYELLyell Immunopharma, Inc.$1.48M0.90%0.45%+2.9%Q1 2026
NSRXNasus Pharma Ltd$1.26M0.77%3.99%Not reportedQ1 2026
PROFProfound Medical Corp.$1.13M0.69%0.47%-40.4%Q4 2025
JSPRJasper Therapeutics, Inc.$1.12M0.68%9.50%Not reportedQ4 2021
PTGXProtagonist Therapeutics, Inc$454K0.28%0.01%Not reportedQ2 2025
CTMXCytomX Therapeutics, Inc.$450K0.27%0.06%-77.8%Q4 2024
NMRANeumora Therapeutics, Inc.$391K0.24%0.12%+187.5%Q1 2026
NRIXNurix Therapeutics, Inc.$388K0.24%0.02%Not reportedQ4 2024
OVIDOvid Therapeutics Inc.$350K0.21%0.07%-18.8%Q4 2024
DTILPrecision Biosciences Inc$314K0.19%0.15%Not reportedQ3 2025
MLYSMineralys Therapeutics, Inc.$297K0.18%0.01%Not reportedQ1 2025
MGNXMacrogenics Inc$277K0.17%0.09%+100.0%Q1 2026
CRBPCorbus Pharmaceuticals Holdings, Inc.$244K0.15%0.14%Not reportedQ3 2024
ARTVArtiva Biotherapeutics, Inc.$243K0.15%0.10%Not reportedQ1 2026
REPLReplimune Group, Inc.$221K0.13%0.02%Not reportedQ4 2024
SNDXSyndax Pharmaceuticals Inc$219K0.13%0.01%Not reportedQ3 2025
IMNMImmunome Inc.$212K0.13%0.01%Not reportedQ1 2025
TECXTectonic Therapeutic, Inc.$206K0.13%0.03%NewQ2 2026
RCKTRocket Pharmaceuticals, Inc.$205K0.12%0.05%-79.6%Q1 2026
KPTIKaryopharm Therapeutics Inc.$195K0.12%0.09%+33.3%Q4 2024
ANTXAN2 Therapeutics, Inc.$194K0.12%0.11%NewQ2 2026
VRDNViridian Therapeutics, Inc.\DE$184K0.11%0.01%-89.0%Q2 2025
SCYXScynexis Inc$163K0.10%0.40%NewQ2 2026
QNRXQuoin Pharmaceuticals, Ltd.$157K0.10%0.05%-61.9%Q1 2026
XLOXilio Therapeutics, Inc.$137K0.08%0.22%Not reportedQ4 2025
NSPRInspireMD, Inc.$104K0.06%0.32%-92.9%Q2 2023
KLRSKalaris Therapeutics, Inc.$102K0.06%0.11%+38.9%Q1 2026
LRMRLarimar Therapeutics, Inc.$101K0.06%0.03%Not reportedQ4 2024
PRQRProQR Therapeutics N.V.$83.7K0.05%0.04%Not reportedQ4 2024
CNTXContext Therapeutics Inc.$33.1K0.02%0.07%-40.3%Q2 2024
GOSSGossamer Bio, Inc.$11.5K0.01%0.01%Not reportedQ3 2023
Q1 2026Reported May 15, 202649 positions
PRAXPraxis Precision Medicines, Inc.$32.5M20.34%0.36%Not reportedQ1 2023
TARAProtara Therapeutics, Inc.$14.8M9.25%5.15%Not reportedQ2 2024
STROSutro Biopharma, Inc.$12.8M7.99%3.09%+64.2%Q4 2024
EVMNEvommune, Inc.$10.3M6.43%1.24%-11.9%Q4 2025
MPLTMapLight Therapeutics, Inc.$10M6.28%1.09%-5.6%Q4 2025
TENXTenax Therapeutics, Inc.$9.33M5.84%2.40%+600.0%Q3 2024
ABVXAbivax S.A.$8.57M5.37%0.10%+14.9%Q3 2025
HRTXHeron Therapeutics, Inc.$7M4.39%4.64%Not reportedQ4 2022
IMMXImmix Biopharma, Inc.$6.74M4.22%1.40%+2014.3%Q2 2025
ESPREsperion Therapeutics, Inc.$4.71M2.95%0.67%+42.2%Q4 2025
EDSAEdesa Biotech, Inc.$4.33M2.71%9.31%+20.4%Q4 2022
AVRAnteris Technologies Global Corp.$3.89M2.43%0.72%NewQ1 2026
NSPRInspireMD, Inc.$3.42M2.14%4.48%-2.1%Q2 2023
XNCRXencor Inc$3.02M1.89%0.34%NewQ1 2026
AVTXAvalo Therapeutics, Inc.$2.76M1.73%0.75%-29.8%Q4 2024
EPRXEupraxia Pharmaceuticals Inc.$2.55M1.60%0.68%Not reportedQ3 2025
CTMXCytomX Therapeutics, Inc.$2.54M1.59%0.32%+575.0%Q4 2024
VRCAVerrica Pharmaceuticals Inc.$2.49M1.56%2.75%Not reportedQ4 2025
JSPRJasper Therapeutics, Inc.$2.34M1.46%9.53%Not reportedQ4 2021
RZLTRezolute, Inc.$2.29M1.43%0.78%Not reportedQ4 2021
LYELLyell Immunopharma, Inc.$2.05M1.28%0.44%NewQ1 2026
PROFProfound Medical Corp.$1.85M1.16%0.79%Not reportedQ4 2025
VRDNViridian Therapeutics, Inc.\DE$1.78M1.12%0.09%+5.3%Q2 2025
RCKTRocket Pharmaceuticals, Inc.$1.05M0.66%0.27%NewQ1 2026
KZIAKazia Therapeutics Ltd$1.01M0.63%0.02%-54.9%Q4 2025
NSRXNasus Pharma Ltd$798K0.50%3.99%NewQ1 2026
QNRXQuoin Pharmaceuticals, Ltd.$560K0.35%0.12%NewQ1 2026
ARWRArrowhead Pharmaceuticals, Inc.$408K0.26%0.00%Not reportedQ3 2025
PTGXProtagonist Therapeutics, Inc$390K0.24%0.01%Not reportedQ2 2025
OVIDOvid Therapeutics Inc.$355K0.22%0.10%Not reportedQ4 2024
MLYSMineralys Therapeutics, Inc.$298K0.19%0.01%-92.7%Q1 2025
CNTXContext Therapeutics Inc.$262K0.16%0.11%Not reportedQ2 2024
NRIXNurix Therapeutics, Inc.$248K0.16%0.02%Not reportedQ4 2024
CRBPCorbus Pharmaceuticals Holdings, Inc.$244K0.15%0.15%+100.0%Q3 2024
SNDXSyndax Pharmaceuticals Inc$234K0.15%0.01%-92.3%Q3 2025
DTILPrecision Biosciences Inc$220K0.14%0.16%+100.0%Q3 2025
IMNMImmunome Inc.$219K0.14%0.01%Not reportedQ1 2025
DSGNDesign Therapeutics, Inc.$213K0.13%0.03%Not reportedQ1 2025
ARTVArtiva Biotherapeutics, Inc.$161K0.10%0.10%NewQ1 2026
NMRANeumora Therapeutics, Inc.$156K0.10%0.04%NewQ1 2026
REPLReplimune Group, Inc.$153K0.10%0.02%+33.3%Q4 2024
LRMRLarimar Therapeutics, Inc.$149K0.09%0.03%Not reportedQ4 2024
XLOXilio Therapeutics, Inc.$120K0.08%0.25%+17.6%Q4 2025
KLRSKalaris Therapeutics, Inc.$104K0.07%0.08%NewQ1 2026
PMVPPMV Pharmaceuticals, Inc.$90.5K0.06%0.14%+108.6%Q4 2024
MGNXMacrogenics Inc$86.7K0.05%0.05%NewQ1 2026
KPTIKaryopharm Therapeutics Inc.$83.6K0.05%0.07%Not reportedQ4 2024
PRQRProQR Therapeutics N.V.$72.9K0.05%0.04%Not reportedQ4 2024
GOSSGossamer Bio, Inc.$23K0.01%0.03%Not reportedQ3 2023
Q4 2025Reported Feb 13, 202645 positions
PRAXPraxis Precision Medicines, Inc.$29.7M17.23%0.40%-24.1%Q1 2023
CDTXCidara Therapeutics, Inc.$23.9M13.89%0.34%Not reportedQ2 2025
TARAProtara Therapeutics, Inc.$15.1M8.76%5.29%+32.5%Q2 2024
HRTXHeron Therapeutics, Inc.$11.4M6.60%4.65%Not reportedQ4 2022
MPLTMapLight Therapeutics, Inc.$9.17M5.32%1.19%NewQ4 2025
ABVXAbivax S.A.$9.04M5.24%0.09%+4.1%Q3 2025
EVMNEvommune, Inc.$8.68M5.03%1.61%NewQ4 2025
MLYSMineralys Therapeutics, Inc.$5.48M3.18%0.19%-14.0%Q1 2025
LNTHLantheus Holdings, Inc.$4.97M2.88%0.12%+1.6%Q4 2021
JSPRJasper Therapeutics, Inc.$4.88M2.83%9.53%Not reportedQ4 2021
AVTXAvalo Therapeutics, Inc.$4.79M2.78%1.42%Not reportedQ4 2024
ESPREsperion Therapeutics, Inc.$4.48M2.60%0.51%NewQ4 2025
VRCAVerrica Pharmaceuticals Inc.$3.92M2.27%2.75%NewQ4 2025
NSPRInspireMD, Inc.$3.82M2.21%4.92%Not reportedQ2 2023
RAPTRAPT Therapeutics, Inc.$3.66M2.12%0.39%+35.0%Q4 2021
STROSutro Biopharma, Inc.$3.61M2.09%3.63%Not reportedQ4 2024
TERNTerns Pharmaceuticals, Inc.$2.83M1.64%0.06%+250.0%Q4 2022
SNDXSyndax Pharmaceuticals Inc$2.73M1.58%0.15%Not reportedQ3 2025
VRDNViridian Therapeutics, Inc.\DE$2.69M1.56%0.08%Not reportedQ2 2025
EPRXEupraxia Pharmaceuticals Inc.$2.66M1.54%0.68%Not reportedQ3 2025
TRVITrevi Therapeutics, Inc.$2.57M1.49%0.16%Not reportedQ3 2025
PROFProfound Medical Corp.$2.25M1.30%0.79%NewQ4 2025
KZIAKazia Therapeutics Ltd$2.07M1.20%0.04%NewQ4 2025
RZLTRezolute, Inc.$1.77M1.03%0.78%Not reportedQ4 2021
TENXTenax Therapeutics, Inc.$1.02M0.59%0.89%Not reportedQ3 2024
EDSAEdesa Biotech, Inc.$976K0.57%8.25%Not reportedQ4 2022
ARWRArrowhead Pharmaceuticals, Inc.$432K0.25%0.00%Not reportedQ3 2025
VTYXVentyx Biosciences, Inc.$361K0.21%0.06%Not reportedQ4 2024
CTMXCytomX Therapeutics, Inc.$341K0.20%0.05%Not reportedQ4 2024
PTGXProtagonist Therapeutics, Inc$323K0.19%0.01%Not reportedQ2 2025
NRIXNurix Therapeutics, Inc.$304K0.18%0.02%Not reportedQ4 2024
OVIDOvid Therapeutics Inc.$261K0.15%0.12%Not reportedQ4 2024
GOSSGossamer Bio, Inc.$217K0.13%0.03%Not reportedQ3 2023
IMNMImmunome Inc.$215K0.12%0.01%Not reportedQ1 2025
DSGNDesign Therapeutics, Inc.$188K0.11%0.03%Not reportedQ1 2025
IMMXImmix Biopharma, Inc.$183K0.11%0.07%Not reportedQ2 2025
CNTXContext Therapeutics Inc.$147K0.09%0.11%Not reportedQ2 2024
REPLReplimune Group, Inc.$146K0.08%0.02%-25.0%Q4 2024
LRMRLarimar Therapeutics, Inc.$126K0.07%0.04%Not reportedQ4 2024
XLOXilio Therapeutics, Inc.$109K0.06%3.75%NewQ4 2025
CRBPCorbus Pharmaceuticals Holdings, Inc.$106K0.06%0.07%-78.7%Q3 2024
PRQRProQR Therapeutics N.V.$90.9K0.05%0.04%Not reportedQ4 2024
DTILPrecision Biosciences Inc$83.2K0.05%0.08%Not reportedQ3 2025
PYXSPyxis Oncology, Inc.$46K0.03%0.06%-27.3%Q2 2025
PMVPPMV Pharmaceuticals, Inc.$43.8K0.03%0.07%Not reportedQ4 2024
Q3 2025Reported Nov 14, 202549 positions
HRTXHeron Therapeutics, Inc.$11M10.36%5.71%+25.3%Q4 2022
CDTXCidara Therapeutics, Inc.$10.4M9.75%0.37%+8.4%Q2 2025
TARAProtara Therapeutics, Inc.$9.3M8.74%5.54%Not reportedQ2 2024
RZLTRezolute, Inc.$7.05M6.62%0.82%Not reportedQ4 2021
PRAXPraxis Precision Medicines, Inc.$7.04M6.61%0.63%-11.1%Q1 2023
MLYSMineralys Therapeutics, Inc.$6.66M6.25%0.22%+0.6%Q1 2025
JSPRJasper Therapeutics, Inc.$6.21M5.83%9.54%+86.1%Q4 2021
ABVXAbivax S.A.$5.47M5.13%0.10%NewQ3 2025
NSPRInspireMD, Inc.$5.17M4.85%5.11%+137.1%Q2 2023
ZOOZZOOZ Strategy Ltd.$4.28M4.02%16.47%NewQ3 2025
ALMSAlumis Inc.$3.78M3.55%Not reported-41.6%Q2 2025
LNTHLantheus Holdings, Inc.$3.77M3.54%0.10%Not reportedQ4 2021
AVTXAvalo Therapeutics, Inc.$3.35M3.15%1.48%+70.1%Q4 2024
STROSutro Biopharma, Inc.$2.71M2.54%3.67%+2.0%Q4 2024
EPRXEupraxia Pharmaceuticals Inc.$2.08M1.95%0.99%NewQ3 2025
RAPTRAPT Therapeutics, Inc.$2.06M1.94%0.48%Not reportedQ4 2021
SNDXSyndax Pharmaceuticals Inc$2M1.88%0.15%NewQ3 2025
TRVITrevi Therapeutics, Inc.$1.88M1.76%0.16%NewQ3 2025
QUREuniQure N.V.$1.87M1.75%0.05%NewQ3 2025
VRDNViridian Therapeutics, Inc.\DE$1.87M1.75%0.11%Not reportedQ2 2025
EDSAEdesa Biotech, Inc.$1.7M1.60%9.63%Not reportedQ4 2022
TELATELA Bio, Inc.$1.11M1.05%1.85%Not reportedQ4 2021
ELDNEledon Pharmaceuticals, Inc.$899K0.84%0.58%+2.4%Q4 2024
CRBPCorbus Pharmaceuticals Holdings, Inc.$772K0.72%0.49%+3.4%Q3 2024
TENXTenax Therapeutics, Inc.$634K0.60%1.41%Not reportedQ3 2024
TRMLTourmaline Bio, Inc.$277K0.26%0.02%-98.5%Q4 2023
CTMXCytomX Therapeutics, Inc.$255K0.24%0.05%+6.7%Q4 2024
PTGXProtagonist Therapeutics, Inc$246K0.23%0.01%Not reportedQ2 2025
ARWRArrowhead Pharmaceuticals, Inc.$224K0.21%0.00%NewQ3 2025
OVIDOvid Therapeutics Inc.$208K0.20%0.22%Not reportedQ4 2024
GOSSGossamer Bio, Inc.$184K0.17%0.03%-6.7%Q3 2023
ALECAlector, Inc.$163K0.15%0.05%Not reportedQ4 2024
DSGNDesign Therapeutics, Inc.$151K0.14%0.04%Not reportedQ1 2025
TERNTerns Pharmaceuticals, Inc.$150K0.14%0.02%Not reportedQ4 2022
NRIXNurix Therapeutics, Inc.$148K0.14%0.02%+60.0%Q4 2024
ERASErasca, Inc.$142K0.13%0.02%Not reportedQ1 2025
VTYXVentyx Biosciences, Inc.$124K0.12%0.06%Not reportedQ4 2024
PYXSPyxis Oncology, Inc.$122K0.11%0.09%+37.5%Q2 2025
IMNMImmunome Inc.$117K0.11%0.01%Not reportedQ1 2025
DTILPrecision Biosciences Inc$110K0.10%0.17%NewQ3 2025
WVEWave Life Sciences, Inc.$110K0.10%0.01%Not reportedQ4 2024
GERNGeron Corp$110K0.10%0.01%+14.3%Q1 2023
LRMRLarimar Therapeutics, Inc.$107K0.10%0.04%Not reportedQ4 2024
CNTXContext Therapeutics Inc.$96.9K0.09%0.11%Not reportedQ2 2024
PRQRProQR Therapeutics N.V.$95.9K0.09%0.04%Not reportedQ4 2024
REPLReplimune Group, Inc.$83.8K0.08%0.03%-89.1%Q4 2024
IMMXImmix Biopharma, Inc.$73.2K0.07%0.11%+40.0%Q2 2025
ACRSAclaris Therapeutics, Inc.$62.1K0.06%0.03%Not reportedQ4 2023
PMVPPMV Pharmaceuticals, Inc.$49K0.05%0.07%Not reportedQ4 2024
Premium opens every quarter this fund has filed

Not investment advice. We make every effort to keep the information on SpoorBase accurate, but errors may occur. SpoorBase does not guarantee the accuracy or completeness of any data, and any use of the information is at the user’s sole responsibility. Valuation multiples are calculated by SpoorBase and may contain errors. See Disclosures. © 2026 SpoorBase. All rights reserved.